Close Menu

Tecan

Luminex said that it expects to launch the platform, to be called NeoPlex4, in 2011 and "once it receives regulatory clearance, [it] will be a fully automated, walk-away testing platform for multiplexed newborn screening."

NuGen's products will be used for an initiative that the Framingham Heart Study launched last year called the Systems Approach to Biomarker Research in Cardiovascular Disease, or SABRe CVD.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Princeton University, Point-2-Point Genomics, PHRI at UMDNJ/NJMS, and NuGen Technologies awarded US patents.

The method the two companies developed integrates PhyNexus' PhyTip columns with Tecan's Freedom Evo liquid handling platform.

The certification will make it easier for customers to develop diagnostic tests incorporating NuGen's sample prep products. Meantime, Takara will distribute NuGen's next-gen sequencing, microarray, qPCR, and sample prep products in Japan, South Korea, and China.

New Products: Jun 15, 2010

Premium

NuGen's Encore NGS Library/Multiplex Systems and Ovation 3'-DGE System, OpGen's Argus Optical Mapping System

As part of the deal, Takara has rights to offer services using NuGen products in Japan, South Korea, and China.

When most people think of the array market, they might think of the whole-genome genotyping chips sold by firms like Affymetrix and Illumina. But for providers of array slides, printers, and scanners, the market increasingly is in protein chips, and business is good.

The companies have integrated the Freedom EVO and Octet instruments.

Pages

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.